Latest filing published 04 Oct 2021 for Adverum Biotechnologies, Inc., €8,935.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Julie Clark: trading record in brief
Julie Clark, listed as senior executive, appears in our data through filings on Adverum Biotechnologies, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 6 August 2021 to 30 September 2021.
Sales make up the whole of the open-market record (1 sale, €8,935). Other entries cover 1 share grant.
Most recently, on 4 October 2021, the filings show an open-market sale worth €8,935 in Adverum Biotechnologies, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julie Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,766 shares@ US$2.17100.0% of flowCommon StockSEC:0001209191-21-059094:0
- 120,000 shares0Common StockSEC:0001209191-21-050750:0
2 of 2 declarations